The anti-inflammatory effects of fasting, evidenced by reductions in hs-CRP levels, are of particular relevance in the context of T2DM, as chronic low-grade inflammation is implicated in the pathogenesis of insulin resistance and metabolic dysfunction (21). Here, MAP3K14 is linked to Insulin resistance.